Lu Yao

Lu Yao

Company: Poseida Therapeutics

Job title: Senior Scientist


An Allogeneic TCR-T Cell Therapy for COVID-19 2:30 pm

A fully allogeneic TCR-T therapy for COVID-19 was created using Poseida’s core nonviral technologies: piggyBac® DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System, and Booster Molecule Three lead TCRs, each recognizing a different immunodominant HLA-A*02:01 restricted epitope in three separate SARS-CoV-2 proteins, were developed for optimal functional avidity TCR-T products were produced and effector function…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.